Theravance Biopharma TBPH Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's net income?
- Theravance Biopharma (TBPH) reported net income of -$4.93M in Q1 2026.
- How has Theravance Biopharma's net income changed year-over-year?
- Theravance Biopharma's net income increased by 63.7% year-over-year, from -$13.58M to -$4.93M.
- What is the long-term trend for Theravance Biopharma's net income?
- Over 4 years (2021 to 2025), Theravance Biopharma's net income has grown at a -14.6% compound annual growth rate (CAGR), from -$199.43M to $105.9M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.